Tandem Diabetes Care

Recent news

• Rating change
  Citi Maintains Tandem Diabetes Care(TNDM.US) With Hold Rating, Raises Target Price to $24
  Market Newswire · 2026/8/14
• Rating change
  Analysts' Top NA Picks: StandardAero, Inc. (SARO), Tandem Diabetes Care (TNDM)
  TipRanks · 2026/8/7
• Rating change
  Analysts Offer Insights on NA Companies: Springer Nature AG & Co. KGaA (OtherSPGDF), Lionsgate Studios (LION) and Tandem Diabetes Care (TNDM)
  TipRanks · 2026/8/7
• Rating change
  CCORF Maintains Tandem Diabetes Care(TNDM.US) With Buy Rating, Maintains Target Price $40
  Market Newswire · 2026/8/12
• Rating change
  UBS Maintains Tandem Diabetes Care(TNDM.US) With Hold Rating, Cuts Target Price to $18
  Market Newswire · 2026/7/29
• RBC Capital Maintains Tandem Diabetes Care(TNDM.US) With Buy Rating, Maintains Target Price $26
  Market Newswire · 2026/10/3
• Barclays Downgrades Tandem Diabetes Care(TNDM.US) to Hold Rating, Cuts Target Price to $18
  Market Newswire · 2026/10/7
• Citi Maintains Tandem Diabetes Care(TNDM.US) With Hold Rating, Maintains Target Price $20
  Market Newswire · 2026/10/2
• Rating change
  A Quick Look at Today's Ratings for Tandem Diabetes Care(TNDM.US), With a Forecast Between $21 to $50
  Market Newswire · 2026/8/8
• Rating change
  Truist Financial Maintains Tandem Diabetes Care(TNDM.US) With Buy Rating, Cuts Target Price to $28
  Market Newswire · 2026/9/24
• Rating change
  Wells Fargo Upgrades Tandem Diabetes Care(TNDM.US) to Buy Rating, Raises Target Price to $27
  Market Newswire · 2026/6/1
• Lake Street Maintains Tandem Diabetes Care(TNDM.US) With Buy Rating, Maintains Target Price $50
  Market Newswire · 2026/9/28
• Rating change
  William Blair Initiates Tandem Diabetes Care(TNDM.US) With Buy Rating
  Market Newswire · 2026/8/21
• Rating change
  A Quick Look at Today's Ratings for Tandem Diabetes Care(TNDM.US), With a Forecast Between $21 to $40
  Market Newswire · 2026/8/7
• Citi Maintains Tandem Diabetes Care(TNDM.US) With Hold Rating, Cuts Target Price to $20
  Market Newswire · 2026/9/30
• Rating change
  BofA Securities Maintains Tandem Diabetes Care(TNDM.US) With Hold Rating, Maintains Target Price $25
  Market Newswire · 2026/6/9
• Rating change
  RBC Capital Maintains Tandem Diabetes Care(TNDM.US) With Buy Rating, Maintains Target Price $30
  Market Newswire · 2026/7/14
• Rating change
  Mizuho Securities Maintains Tandem Diabetes Care(TNDM.US) With Hold Rating, Cuts Target Price to $20
  Market Newswire · 2026/7/15
• Rating change
  Citi Maintains Tandem Diabetes Care(TNDM.US) With Hold Rating, Maintains Target Price $17
  Market Newswire · 2026/7/8
• Rating change
  Wells Fargo Maintains Tandem Diabetes Care(TNDM.US) With Buy Rating, Maintains Target Price $27
  Market Newswire · 2026/6/1

Headlines are aggregated automatically and are not independently verified or edited by our team.